Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christine Z. Oak"'
Autor:
Sanjay Gupta, Firouz Daneshgari, Yvonne Parker, Daniel J. Lindner, Chris A. Flask, Gregory T. MacLennan, Christine Z. Oak, Joseph P. Molter, Michelle A. Puchowicz, Edwin J. Vazquez, Pingfu Fu, Sanjeev Shukla, Melissa A. Babcook
Figure S1. HMG-CoAR protein is over-expressed and its degradation dysregulated in omCRPC cell lines. Figure S2. Total cholesterol significantly increased in omCRPC cell lines. Figure S3. Cellular free-to-total cholesterol ratio minimally affected by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::010329ed8e26cb4a48e0d4b1279a3c3d
https://doi.org/10.1158/1535-7163.22502677
https://doi.org/10.1158/1535-7163.22502677
Autor:
Sanjay Gupta, Firouz Daneshgari, Yvonne Parker, Daniel J. Lindner, Chris A. Flask, Gregory T. MacLennan, Christine Z. Oak, Joseph P. Molter, Michelle A. Puchowicz, Edwin J. Vazquez, Pingfu Fu, Sanjeev Shukla, Melissa A. Babcook
Docetaxel chemotherapy remains a standard of care for metastatic castration-resistant prostate cancer (CRPC). Docetaxel modestly increases survival, yet results in frequent occurrence of side effects and resistant disease. An alternate chemotherapy w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::499e853c27b0ea49356e290d5c9d45f6
https://doi.org/10.1158/1535-7163.c.6537145
https://doi.org/10.1158/1535-7163.c.6537145
Publikováno v:
Cancer Research. 74:804-804
Limited chemotherapeutic options exist for metastatic castration-resistant prostate cancer (CRPC). We have previously demonstrated that 1:500 combination simvastatin (SIM) and metformin (MET) synergistically inhibits cell viability, invasion, migrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b50ac8729f2390845bd8fca2cd5dd36
https://doi.org/10.1158/1538-7445.am2014-804
https://doi.org/10.1158/1538-7445.am2014-804
